President Biden three times dodged questions about whether he'd take a neurological test in one of the more contentious moments of his first sit-down interview since a widely panned presidential ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

"But no ones suggesting that to me now," the president said at the NATO summit on Thursday. His assurances come as pressure mounts for him to prove his cognitive fitness before the elections. Facing ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

President Biden said he undergoes “a full neurological test every day” in his first interview since his disastrous debate against Donald Trump last week — but revealed he would not undergo an ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...

TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which ...